Holocene Advisors LP Boosts Stock Holdings in Balchem Co. (NASDAQ:BCPC)

Holocene Advisors LP lifted its position in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 596.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,242 shares of the basic materials company's stock after buying an additional 12,196 shares during the quarter. Holocene Advisors LP's holdings in Balchem were worth $2,507,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the company. nVerses Capital LLC acquired a new position in shares of Balchem in the 3rd quarter valued at about $35,000. Blue Trust Inc. grew its position in shares of Balchem by 642.5% during the 3rd quarter. Blue Trust Inc. now owns 839 shares of the basic materials company's stock worth $148,000 after buying an additional 726 shares during the period. GAMMA Investing LLC lifted its position in shares of Balchem by 73.4% during the 3rd quarter. GAMMA Investing LLC now owns 841 shares of the basic materials company's stock valued at $148,000 after acquiring an additional 356 shares during the period. Private Advisor Group LLC acquired a new stake in Balchem in the third quarter worth $220,000. Finally, TD Asset Management Inc bought a new stake in Balchem in the second quarter valued at $200,000. Institutional investors own 87.91% of the company's stock.

Analysts Set New Price Targets

BCPC has been the topic of a number of research analyst reports. StockNews.com raised shares of Balchem from a "hold" rating to a "buy" rating in a research report on Monday, October 28th. HC Wainwright increased their price target on Balchem from $185.00 to $190.00 and gave the stock a "buy" rating in a report on Monday, November 4th.

Balchem Stock Up 0.7 %

BCPC traded up $1.15 during trading on Friday, hitting $177.53. 64,233 shares of the company's stock were exchanged, compared to its average volume of 109,648. The stock has a market cap of $5.77 billion, a P/E ratio of 47.72, a PEG ratio of 5.32 and a beta of 0.67. The business's 50 day moving average is $174.75 and its two-hundred day moving average is $168.07. Balchem Co. has a fifty-two week low of $131.10 and a fifty-two week high of $186.03. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.